立方制药(003020)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

003020 立方制药

已收盘 07-18 15:00:00

{"stockData":{"symbol":"003020","market":"SZ","secType":"STK","nameCN":"立方制药","latestPrice":16.6,"timestamp":1721286186000,"preClose":16.59,"halted":0,"volume":966088,"delay":0,"floatShares":137000000,"shares":192000000,"eps":0.9966,"marketStatus":"已收盘","marketStatusCode":5,"change":0.01,"latestTime":"07-18 15:00:00","open":16.5,"high":16.69,"low":16.28,"amount":15924100,"amplitude":0.0247,"askPrice":16.6,"askSize":14,"bidPrice":16.56,"bidSize":18,"shortable":0,"etf":0,"ttmEps":0.9966,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721352600000},"adr":0,"adjPreClose":16.59,"symbolType":"stock","openAndCloseTimeList":[[1721266200000,1721273400000],[1721278800000,1721286000000]],"highLimit":18.25,"lowLimit":14.93,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":191571763,"pbRate":1.85,"roa":"--","roe":"1.78%","epsLYR":1.42,"committee":-0.014663,"marketValue":3180000000,"floatMarketCap":2276000000,"peRate":16.656633,"changeRate":0.0006,"turnoverRate":0.007,"status":0},"requestUrl":"/m/hq/s/003020/tweets","defaultTab":"tweets","newsList":[{"id":"2449747985","title":"立方制药（003020）7月8日主力资金净卖出82.14万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2449747985","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449747985?lang=zh_cn&edition=full","pubTime":"2024-07-08 15:27","pubTimestamp":1720423668,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年7月8日收盘，立方制药报收于15.96元，下跌5.67%，换手率0.74%，成交量1.01万手，成交额1646.73万元。7月8日的资金流向数据方面，主力资金净流出82.14万元，占总成交额4.99%，游资资金净流出77.34万元，占总成交额4.7%，散户资金净流入159.48万元，占总成交额9.68%。立方制药主营业务：药品制剂及原料药的研发、生产、销售,药品与医疗器械的批发、零售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070800014380.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","003020"],"gpt_icon":0},{"id":"2448415099","title":"立方制药（003020）7月4日主力资金净卖出275.32万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448415099","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448415099?lang=zh_cn&edition=full","pubTime":"2024-07-04 15:31","pubTimestamp":1720078284,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年7月4日收盘，立方制药报收于16.31元，下跌5.01%，换手率2.38%，成交量3.27万手，成交额5368.87万元。7月4日的资金流向数据方面，主力资金净流出275.32万元，占总成交额5.13%，游资资金净流入396.25万元，占总成交额7.38%，散户资金净流出120.93万元，占总成交额2.25%。立方制药主营业务：药品制剂及原料药的研发、生产、销售,药品与医疗器械的批发、零售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070400025044.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","003020"],"gpt_icon":0},{"id":"2446860716","title":"立方制药（003020）6月25日主力资金净卖出36.08万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446860716","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446860716?lang=zh_cn&edition=full","pubTime":"2024-06-25 15:22","pubTimestamp":1719300170,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年6月25日收盘，立方制药报收于18.4元，上涨3.37%，换手率0.84%，成交量1.15万手，成交额2082.33万元。6月25日的资金流向数据方面，主力资金净流出36.08万元，占总成交额1.73%，游资资金净流入33.58万元，占总成交额1.61%，散户资金净流入2.5万元，占总成交额0.12%。立方制药主营业务：药品制剂及原料药的研发、生产、销售,药品与医疗器械的批发、零售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062500023945.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003020","BK0250"],"gpt_icon":0},{"id":"2445074112","title":"立方制药（003020）股东邓晓娟质押100万股，占总股本0.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2445074112","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445074112?lang=zh_cn&edition=full","pubTime":"2024-06-24 21:25","pubTimestamp":1719235537,"startTime":"0","endTime":"0","summary":"证券之星消息，立方制药6月24日公开信息显示，股东邓晓娟向兴业银行股份有限公司合肥分行合计质押100.0万股，占总股本0.52%。质押详情见下表：截止本公告日，股东邓晓娟已累计质押股份196.0万股，占其持股总数的17.57%。立方制药主营业务：药品制剂及原料药的研发、生产、销售,药品与医疗器械的批发、零售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062400032572.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","003020"],"gpt_icon":0},{"id":"2444917201","title":"立方制药（003020）6月18日主力资金净卖出569.39万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444917201","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444917201?lang=zh_cn&edition=full","pubTime":"2024-06-18 15:25","pubTimestamp":1718695525,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年6月18日收盘，立方制药报收于19.18元，下跌1.79%，换手率1.2%，成交量1.65万手，成交额3142.46万元。6月18日的资金流向数据方面，主力资金净流出569.39万元，占总成交额18.12%，游资资金净流入226.02万元，占总成交额7.19%，散户资金净流入343.37万元，占总成交额10.93%。立方制药主营业务：药品制剂及原料药的研发、生产、销售,药品与医疗器械的批发、零售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024061800023647.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","003020"],"gpt_icon":0},{"id":"2439523279","title":"5月31日立方制药现1笔折价11.92%的大宗交易 合计成交739.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439523279","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439523279?lang=zh_cn&edition=full","pubTime":"2024-05-31 16:40","pubTimestamp":1717144827,"startTime":"0","endTime":"0","summary":"证券之星消息，5月31日立方制药发生大宗交易，交易数据如下：大宗交易成交价格18.48元，相对当日收盘价折价11.92%，成交40万股，成交金额739.2万元，买方营业部为太平洋证券股份有限公司合肥屯溪路证券营业部，卖方营业部为太平洋证券股份有限公司上海临港新片区证券营业部。近三个月该股共发生3笔大宗交易，合计成交1.26万手，折价成交3笔。截至2024年5月31日收盘，立方制药报收于20.98元，上涨2.29%，换手率1.27%，成交量1.74万手，成交额3612.97万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024053100030461.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003020","BK0250"],"gpt_icon":0},{"id":"2439692877","title":"5月30日立方制药现1614.22万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2439692877","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439692877?lang=zh_cn&edition=full","pubTime":"2024-05-30 16:33","pubTimestamp":1717057980,"startTime":"0","endTime":"0","summary":"证券之星消息，5月30日立方制药发生大宗交易，交易数据如下：近三个月该股共发生2笔大宗交易，合计成交8600.0手，折价成交2笔。该股在过去半年内已有共计4202.55万股限售解禁股上市，占公司总股本的21.94%。截至2024年5月30日收盘，立方制药报收于20.51元，下跌1.63%，换手率1.06%，成交量1.45万手，成交额2998.63万元。该股最近90天内共有2家机构给出评级，买入评级2家。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024053000029575.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","003020"],"gpt_icon":0},{"id":"2439513963","title":"立方制药（003020）5月29日主力资金净卖出180.99万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439513963","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439513963?lang=zh_cn&edition=full","pubTime":"2024-05-29 15:28","pubTimestamp":1716967693,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年5月29日收盘，立方制药报收于20.85元，下跌1.84%，换手率1.17%，成交量1.61万手，成交额3364.42万元。5月29日的资金流向数据方面，主力资金净流出180.99万元，占总成交额5.38%，游资资金净流出132.25万元，占总成交额3.93%，散户资金净流入313.24万元，占总成交额9.31%。立方制药主营业务：药品制剂及原料药的研发、生产、销售,药品与医疗器械的批发、零售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024052900025390.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","003020"],"gpt_icon":0},{"id":"2438810911","title":"【机构调研记录】湘财基金调研立方制药","url":"https://stock-news.laohu8.com/highlight/detail?id=2438810911","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438810911?lang=zh_cn&edition=full","pubTime":"2024-05-27 08:02","pubTimestamp":1716768144,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及5月24日披露的机构调研信息，湘财基金近期对1家上市公司进行了调研，相关名单如下：1）立方制药 个股亮点：公司旗下亮菌口服溶液主要成分为亮菌多糖多肽，主要适应症为用于慢性肝炎、迁延性肝炎、慢性胆管炎和胆囊炎以及慢性、浅表性、萎缩性胃炎及放疗、化疗引起的白细胞减少的辅助治疗。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024052700000489.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","003020"],"gpt_icon":0},{"id":"2438810663","title":"【机构调研记录】安信基金调研立方制药、亚太科技等5只个股（附名单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2438810663","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438810663?lang=zh_cn&edition=full","pubTime":"2024-05-27 08:01","pubTimestamp":1716768119,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及5月24日披露的机构调研信息，安信基金近期对5家上市公司进行了调研，相关名单如下：1）立方制药 个股亮点：公司旗下亮菌口服溶液主要成分为亮菌多糖多肽，主要适应症为用于慢性肝炎、迁延性肝炎、慢性胆管炎和胆囊炎以及慢性、浅表性、萎缩性胃炎及放疗、化疗引起的白细胞减少的辅助治疗。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024052700000458.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003020","BK0250","BK0233","002540","BK0073","BK0028"],"gpt_icon":0},{"id":"2438109678","title":"【机构调研记录】博时基金调研立方制药、赛微电子等14只个股（附名单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2438109678","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438109678?lang=zh_cn&edition=full","pubTime":"2024-05-27 08:01","pubTimestamp":1716768108,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及5月24日披露的机构调研信息，博时基金近期对14家上市公司进行了调研，相关名单如下：1）立方制药 个股亮点：公司旗下亮菌口服溶液主要成分为亮菌多糖多肽，主要适应症为用于慢性肝炎、迁延性肝炎、慢性胆管炎和胆囊炎以及慢性、浅表性、萎缩性胃炎及放疗、化疗引起的白细胞减少的辅助治疗。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024052700000446.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0125","BK0077","BK0214","003020","BK0250","BK0028","300456","BK0051"],"gpt_icon":0},{"id":"2436617462","title":"立方制药最新公告：2023年度权益分派10转2派5元 股权登记日5月27日","url":"https://stock-news.laohu8.com/highlight/detail?id=2436617462","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2436617462?lang=zh_cn&edition=full","pubTime":"2024-05-20 19:39","pubTimestamp":1716205197,"startTime":"0","endTime":"0","summary":"立方制药公布2023年度权益分派实施公告，公司2023年年度权益分派方案为：向全体股东每10股派5元人民币现金(含税)，同时以资本公积金向全体股东每10股转增2股。本次权益分派股权登记日为：2024年5月27日，除权除息日为：2024年5月28日。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024052000022112.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","003020"],"gpt_icon":0},{"id":"2436171385","title":"立方制药(003020.SZ)2023年度权益分派：每10股转增2股派5元","url":"https://stock-news.laohu8.com/highlight/detail?id=2436171385","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2436171385?lang=zh_cn&edition=full","pubTime":"2024-05-20 19:11","pubTimestamp":1716203498,"startTime":"0","endTime":"0","summary":"智通财经APP讯，立方制药(003020.SZ)发布公告，公司2023年年度权益分派方案为：以公司现有总股本剔除已回购股份0股后为基数，向全体股东每10股派5元人民币现金(含税)，同时，以资本公积金向全体股东每10股转增2股。本次权益分派股权登记日为：2024年5月27日，除权除息日为：2024年5月28日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1123423.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0250","003020"],"gpt_icon":0},{"id":"2436359124","title":"立方制药最新公告：子公司收到洛索洛芬钠口服溶液药品注册受理通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2436359124","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2436359124?lang=zh_cn&edition=full","pubTime":"2024-05-20 16:30","pubTimestamp":1716193819,"startTime":"0","endTime":"0","summary":"立方制药公告，近日，公司全资子公司合肥诚志生物制药有限公司收到国家药品监督管理局下发的洛索洛芬钠口服溶液药品注册上市许可申请的《受理通知书》。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024052000015458.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003020","BK0250"],"gpt_icon":0},{"id":"2436964903","title":"立方制药（003020）5月17日主力资金净卖出7.69万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2436964903","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2436964903?lang=zh_cn&edition=full","pubTime":"2024-05-17 15:28","pubTimestamp":1715930897,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年5月17日收盘，立方制药报收于23.46元，下跌1.01%，换手率1.27%，成交量1.45万手，成交额3406.8万元。5月17日的资金流向数据方面，主力资金净流出7.69万元，占总成交额0.23%，游资资金净流入264.0万元，占总成交额7.75%，散户资金净流出256.3万元，占总成交额7.52%。立方制药主营业务：药品制剂及原料药的研发、生产、销售,药品与医疗器械的批发、零售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051700022239.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","003020"],"gpt_icon":0},{"id":"2435563044","title":"立方制药（003020）5月14日主力资金净买入475.60万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435563044","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435563044?lang=zh_cn&edition=full","pubTime":"2024-05-14 15:28","pubTimestamp":1715671739,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年5月14日收盘，立方制药报收于24.09元，下跌1.55%，换手率3.76%，成交量4.29万手，成交额1.04亿元。5月14日的资金流向数据方面，主力资金净流入475.6万元，占总成交额4.56%，游资资金净流出754.06万元，占总成交额7.23%，散户资金净流入278.46万元，占总成交额2.67%。立方制药主营业务：药品制剂及原料药的研发、生产、销售,药品与医疗器械的批发、零售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051400016102.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","003020"],"gpt_icon":0},{"id":"2431739428","title":"立方制药(003020)3月31日股东户数1.11万户，较上期增加2.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431739428","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431739428?lang=zh_cn&edition=full","pubTime":"2024-04-30 17:27","pubTimestamp":1714469278,"startTime":"0","endTime":"0","summary":"证券之星消息，近日立方制药披露，截至2024年3月31日公司股东户数为1.11万户，较12月31日增加268.0户，增幅为2.48%。在化学制药行业个股中，立方制药股东户数低于行业平均水平，截至3月31日，化学制药行业平均股东户数为3.3万户。从股价来看，2023年12月31日至2024年3月31日，立方制药区间跌幅为24.4%，在此期间股东户数增加268.0户，增幅为2.48%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024043000039072.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","003020"],"gpt_icon":0},{"id":"2431636628","title":"立方制药最新公告：一季度净利润3037.22万元 同比下降54.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431636628","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431636628?lang=zh_cn&edition=full","pubTime":"2024-04-29 21:31","pubTimestamp":1714397460,"startTime":"0","endTime":"0","summary":"立方制药公布2024年一季度报告，报告期营业收入3.34亿元，同比下降58.90%；归属于上市公司股东的净利润3037.22万元，同比下降54.08%。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042900032216.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003020"],"gpt_icon":0},{"id":"2431374855","title":"立方制药(003020.SZ)发一季度业绩，净利润3037.22万元，同比减少54.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431374855","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431374855?lang=zh_cn&edition=full","pubTime":"2024-04-29 20:01","pubTimestamp":1714392087,"startTime":"0","endTime":"0","summary":"智通财经APP讯，立方制药(003020.SZ)发布2024年第一季度报告，报告期内公司实现营业收入3.34亿元，同比减少58.90%;归属于上市公司股东的净利润3037.22万元，同比减少54.08%;归属于上市公司股东扣除非经常性损益净利润2839.84万元，同比减少56.38%;基本每股收益0.19元/股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1114857.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["003020"],"gpt_icon":0},{"id":"2430244791","title":"立方制药最新公告：收到硝苯地平原料药上市申请批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2430244791","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430244791?lang=zh_cn&edition=full","pubTime":"2024-04-26 16:36","pubTimestamp":1714120567,"startTime":"0","endTime":"0","summary":"立方制药公告，收到硝苯地平原料药上市申请批准通知书。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042600036545.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","003020"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2020-12-15","address":"安徽省合肥市蜀山区长江西路669号立方厂区","stockEarnings":[{"period":"1week","weight":-0.0012},{"period":"1month","weight":-0.1505},{"period":"3month","weight":0.0457},{"period":"6month","weight":-0.1689},{"period":"1year","weight":-0.3995},{"period":"ytd","weight":-0.2794}],"companyName":"合肥立方制药股份有限公司","boardCode":"AI0051","perCapita":"12368股","boardName":"批发业","registeredCapital":"19157万元","compareEarnings":[{"period":"1week","weight":0.008},{"period":"1month","weight":-0.0176},{"period":"3month","weight":-0.0362},{"period":"6month","weight":0.0461},{"period":"1year","weight":-0.0735},{"period":"ytd","weight":-0.0041}],"survey":"　　合肥立方制药股份有限公司的主营业务是药品制剂及原料药的研发、生产、销售、药品与医疗器械的批发、零售，其主要产品有非洛地平缓释片（Ⅱ）、非洛地平缓释片、甲磺酸多沙唑嗪缓释片、硝苯地平控释片、盐酸曲美他嗪缓释片、盐酸羟考酮缓释片、盐酸文拉法辛缓释片、益气和胃胶囊、亮菌口服溶液、丹皮酚软膏、克痤隐酮凝胶、金珍滴眼液。","serverTime":1721301838452,"listedPrice":23.13,"stockholders":"11085人(较上一季度减少93.37%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"立方制药(003020)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供立方制药(003020)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"立方制药,003020,立方制药股票,立方制药股票老虎,立方制药股票老虎国际,立方制药行情,立方制药股票行情,立方制药股价,立方制药股市,立方制药股票价格,立方制药股票交易,立方制药股票购买,立方制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"立方制药(003020)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供立方制药(003020)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}